Sign in

CIK 0001635088

  • Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
Operating
EIN
981173944
Phone
+44 12955950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$70,369,463
in 12 filings, $45.5M under 10b5-1 plans

Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-12 Gline Matthew CEO Other disposition −41,179 $40.36 $1.7M 16,400,638
2026-11-12 Gline Matthew CEO Other disposition −7,809 $41.13 $321K 16,392,829
2026-11-12 Gline Matthew CEO Shares withheld for taxes −1,600 $41.85 $67K 16,391,229
2026-11-11 Gline Matthew CEO Other disposition −30,083 $41.63 $1.3M 16,460,722
2026-11-11 Gline Matthew CEO Other disposition −18,905 $42.01 $794K 16,441,817
2026-11-10 Gline Matthew CEO Other disposition −25,841 $40.43 $1.0M 16,523,295
2026-11-10 Gline Matthew CEO Other disposition −32,490 $41.13 $1.3M 16,490,805
2026-10-16 Gline Matthew CEO Shares withheld for taxes −34,638 $33.53 $1.2M 16,549,136
2026-09-30 Gline Matthew CEO Shares withheld for taxes −76,171 $36.57 $2.8M 16,583,774
2026-06-30 Gline Matthew CEO Shares withheld for taxes −76,171 $35.39 $2.7M 16,659,945
2026-04-16 Gline Matthew CEO Sale −289,774 $29.16 $8.4M 16,736,116
2026-03-31 Gline Matthew CEO Shares withheld for taxes −304,684 $27.70 $8.4M 17,025,890
2026-03-30 Gline Matthew CEO Option exercise +97,319 17,384,400
2026-03-30 Gline Matthew CEO Shares withheld for taxes −53,826 $26.41 $1.4M 17,330,574
2026-03-30 Gline Matthew CEO Option exercise · Capped Value Appreciation Rights −2,178,150 $11.50 $25.0M 0
2025-12-15 Gline Matthew CEO Option exercise +234,096 $4.06 $950K 17,521,177
2025-12-15 Gline Matthew CEO Sale −230,357 $21.68 $5.0M 17,290,820
2025-12-15 Gline Matthew CEO Other disposition −3,739 $21.68 $81K 17,287,081
2025-12-15 Gline Matthew CEO Option exercise +1,363,711 $12.68 $17.3M 18,650,792
2025-12-15 Gline Matthew CEO Sale −566,116 $21.68 $12.3M 18,084,676

Page 1 of 4 · 66 trades